Transylvania on the world map of bioinformatics research

Egnosis, the mid-size Transylvanian company using its software engineering experience to find inventive solutions to global medical issues, strengthens international teams of researchers and consortiums. Several years of devoted work reached a bold level by recognizing the potential of a partnership between Egnosis and Pro-Vitam Diagnostics and Research Centre, which has significant added value. While engraving Transylvania on the world map of bioinformatics research, local experts create intellectual property that benefits the local community.

Digitalization, a must-have

Digitalization remains the voice for cutting-edge technologies, as it is no longer an option but a crucial framework both in the private and public spheres. It also marks the field of medicine as more and more undertakings concern paradigm shifts, while artificial intelligence and machine learning deliver unlimited opportunities for the future of medicine. As a basis, international openness and funding are available; only between 2014 and 2020 did the European Union support R&D and its integrations with 80 billion euros within the Horizon 2020 scheme. The EU also launched the Innovation Radar platform to showcase global research and innovations. So far, Gnome Design’s Egnosis stands as the sole entity from Szeklerland listed on this forum, alongside a few contributors from Transylvania.

About Horizon Europe at Egnosis

Egnosis opened up to bioinformatics research and development in 2019. In the vision of executive director Bela Bihari, their Horizon Europe projects go beyond theory and focus on the business potential of medical innovations. The end products of EU projects often remain in the dissemination deck; outcomes and inventions don’t enter the economic cycle. However, the EU provides the necessary financial resources, so the local market does not pay out the product, as it is usually the case for “traditional” IT outcomes. Moreover, intellectual property does not migrate along with the work done. For Egnosis, as a Transylvanian company, the most in-depth motivation is to exert the right of innovation and intellectual property to exploit world-class inventions foremost and enjoy its benefits with the local community.

Research and implementation at Pro-Vitam

Dr. Szilárd Fejér, researcher and head of the Pro Vitam laboratory, catches the essence of cooperation in developing new services from available data using innovative methods. According to him, the health system is well-computerized, which allows the collection of a large amount of valuable digital data. Science can learn a lot from these data, while artificial intelligence and machine learning can solve the critical question of time. Yet, these data are highly sensitive and need protection – not only because of GDPR. During the cooperation, two domain-specific knowledge bases, IT and medicine, meet to create an all-in-one platform to run, develop, and publish federated & privacy-preserving machine learning algorithms. The research results are first implemented at Pro-Vitam, thus exploiting full rights on the process, from accessing raw data to product and service development.

Dr. Fejér Szilárd at the 5th FeatureCloud General Assembly Meeting in Hamburg

Mutual benefits of the cooperation

The two Transylvanian companies proved that a professional partnership in this region can avoid getting lost in the maze of bureaucracy and can advance for the advantage of both domains. The challenge remains ongoing because medicine’s burning questions demand setting the bar very high. Still, information technology and digitalization can radically change existing structures. The partnership between Egnosis and Pro-Vitam strives to show local knowledge and pertinence to contribute to a better future for medicine and mankind.